(Q39207353)

10 September 2017

title

The neuroleptic hypothesis: study of the covariation of extrapyramidal and therapeutic drug effects (English)

1 reference

10 September 2017

The Neuroleptic Hypothesis: Study of the Covariation of Extrapyramidal and Therapeutic Drug Effects (English)

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

5 April 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

author name string

M. Alpert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

F. Diamond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

J. Weisenfreund

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

E. Taleporos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

A. J. Friedhoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354734

5 April 2023

language of work or name

English

0 references

publication date

1 August 1978

1 reference

full work available at URL

10 September 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0007125000003433

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

British Journal of Psychiatry

5 April 2023

published in

1 reference

10 September 2017

volume

133

1 reference

10 September 2017

page(s)

169-175

1 reference

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

10 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

PHENOTHIAZINE-PRODUCED EXTRA-PYRAMIDAL SYSTEM DISTURBANCE

5 April 2023

4

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

The dopamine hypothesis of schizophrenia: a review

5 April 2023

6

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Provocation of Schizophrenic Symptoms by Intravenous Administration of Methylphenidate

5 April 2023

7

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Abnormal symptoms, signs, and laboratory tests during treatment with phenothiazine derivatives

5 April 2023

8

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Psychomotility and parkinsonism in treatment with neuroleptic drugs.

5 April 2023

11

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol

5 April 2023

13

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.

5 April 2023

15

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

A survey of drug-induced extrapyramidal reactions

5 April 2023

16

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Amphetamine psychosis: behavioral and biochemical aspects

5 April 2023

18

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Correlation between extrapyramidal and therapeutic effects of neuroleptics

5 April 2023

21

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Quantification of Sleepiness: A New Approach

5 April 2023

24

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Low platelet monoamine oxidase activity and schizophrenia

5 April 2023

28

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

5 April 2023

29

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. I. Treatment with trifluoperazine singly and in combination with trihexyphenidyl

5 April 2023

30

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

5 April 2023

31

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

Drug-Induced Extrapyramidal Symptoms and Their Relations to Clinical Efficacy

5 April 2023

34

1 reference

https://api.crossref.org/works/10.1192/BJP.133.2.169

5 April 2023

Identifiers

1 reference

10 September 2017

1 reference